MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1882.75%
Quick Ratio
1882.75%
Cash Ratio
1827.76%
Debt to Asset Ratio
5.31%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Goodwill
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
138,343
71,793
44,320
25,297
Restricted cash and cash equivalents
100
100
100
100
Prepaid expenses and other current assets
4,062
3,318
4,631
4,050
Total current assets
142,505
75,211
49,051
29,447
Operating lease right-of-use assets
710
963
556
683
Goodwill
1,914
1,914
1,914
1,914
Deposits and other assets
253
257
34
261
Total assets
145,382
78,345
51,555
32,305
Accounts payable
3,086
2,948
2,305
3,336
Accrued expenses and other current liabilities
3,903
3,525
3,021
2,083
Operating lease liabilities
580
544
599
580
Total current liabilities
7,569
7,017
5,925
5,999
Operating lease liabilities, non-current
157
457
0
157
Total liabilities
7,726
7,474
5,925
6,156
Common stock, 0.0001par value 350,000,000shares authorized, 201,918,874 and 153,103,459shares issued and outstanding at june30, 2026 and december31, 2025, respectively
20
15
12
10
Additional paid-in capital
430,636
345,844
312,948
286,678
Accumulated deficit
-293,000
-274,988
-267,330
-260,539
Total stockholders equity
137,656
70,871
45,630
26,149
Total liabilities and stockholders equity
145,382
78,345
51,555
32,305
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$138,343K (446.88%↑ Y/Y)Prepaid expenses andother current assets$4,062K (0.30%↑ Y/Y)Restricted cash and cashequivalents$100K (0.00%↑ Y/Y)Total current assets$142,505K (383.94%↑ Y/Y)Goodwill$1,914K (0.00%↑ Y/Y)Operating leaseright-of-use assets$710K (3.95%↑ Y/Y)Deposits and other assets$253K (-3.07%↓ Y/Y)Total assets$145,382K (350.03%↑ Y/Y)Total liabilities andstockholders equity$145,382K (350.03%↑ Y/Y)Total stockholdersequity$137,656K (426.43%↑ Y/Y)Total liabilities$7,726K (25.50%↑ Y/Y)Accumulated deficit-$293,000K (-12.46%↓ Y/Y)Additional paid-in capital$430,636K (50.22%↑ Y/Y)Total currentliabilities$7,569K (26.17%↑ Y/Y)Operating leaseliabilities, non-current$157K (0.00%↑ Y/Y)Common stock,0.0001par value...$20K (100.00%↑ Y/Y)Accrued expenses andother current...$3,903K (87.37%↑ Y/Y)Accounts payable$3,086K (-7.49%↓ Y/Y)Operating leaseliabilities$580K (0.00%↑ Y/Y)

SELLAS Life Sciences Group, Inc. (SLS)

SELLAS Life Sciences Group, Inc. (SLS)